233 related articles for article (PubMed ID: 15082796)
1. Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase.
Li Y; Kumar KG; Tang W; Spiegelman VS; Fuchs SY
Mol Cell Biol; 2004 May; 24(9):4038-48. PubMed ID: 15082796
[TBL] [Abstract][Full Text] [Related]
2. The ubiquitin ligase SCF(betaTrCP) regulates the degradation of the growth hormone receptor.
van Kerkhof P; Putters J; Strous GJ
J Biol Chem; 2007 Jul; 282(28):20475-83. PubMed ID: 17500058
[TBL] [Abstract][Full Text] [Related]
3. SCF(β-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway.
Liu J; Wan L; Liu P; Inuzuka H; Liu J; Wang Z; Wei W
Oncotarget; 2014 Feb; 5(4):1026-37. PubMed ID: 24657926
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin E3 ligase SCF(β-TRCP) regulates TRIB2 stability in liver cancer cells.
Qiao Y; Zhang Y; Wang J
Biochem Biophys Res Commun; 2013 Nov; 441(3):555-9. PubMed ID: 24211582
[TBL] [Abstract][Full Text] [Related]
5. M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP.
Watanabe N; Arai H; Nishihara Y; Taniguchi M; Watanabe N; Hunter T; Osada H
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4419-24. PubMed ID: 15070733
[TBL] [Abstract][Full Text] [Related]
6. Oncogene-mediated inhibition of glycogen synthase kinase 3 beta impairs degradation of prolactin receptor.
Plotnikov A; Li Y; Tran TH; Tang W; Palazzo JP; Rui H; Fuchs SY
Cancer Res; 2008 Mar; 68(5):1354-61. PubMed ID: 18316598
[TBL] [Abstract][Full Text] [Related]
7. DEPTOR ubiquitination and destruction by SCF(β-TrCP).
Wang Z; Zhong J; Gao D; Inuzuka H; Liu P; Wei W
Am J Physiol Endocrinol Metab; 2012 Jul; 303(2):E163-9. PubMed ID: 22454292
[TBL] [Abstract][Full Text] [Related]
8. The SCF
Lou Y; Han M; Song Y; Zhong J; Zhang W; Chen YH; Wang H
J Immunol; 2020 Apr; 204(8):2122-2132. PubMed ID: 32188758
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of prolactin receptor in breast cancer cells.
Li Y; Clevenger CV; Minkovsky N; Kumar KG; Raghunath PN; Tomaszewski JE; Spiegelman VS; Fuchs SY
Oncogene; 2006 Mar; 25(13):1896-902. PubMed ID: 16278670
[TBL] [Abstract][Full Text] [Related]
10. The SCFβ-TRCP E3 ubiquitin ligase complex targets Lipin1 for ubiquitination and degradation to promote hepatic lipogenesis.
Shimizu K; Fukushima H; Ogura K; Lien EC; Nihira NT; Zhang J; North BJ; Guo A; Nagashima K; Nakagawa T; Hoshikawa S; Watahiki A; Okabe K; Yamada A; Toker A; Asara JM; Fukumoto S; Nakayama KI; Nakayama K; Inuzuka H; Wei W
Sci Signal; 2017 Jan; 10(460):. PubMed ID: 28049764
[TBL] [Abstract][Full Text] [Related]
11. SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection.
Tan M; Gallegos JR; Gu Q; Huang Y; Li J; Jin Y; Lu H; Sun Y
Neoplasia; 2006 Dec; 8(12):1042-54. PubMed ID: 17217622
[TBL] [Abstract][Full Text] [Related]
12. The ubiquitin-specific protease USP47 is a novel beta-TRCP interactor regulating cell survival.
Peschiaroli A; Skaar JR; Pagano M; Melino G
Oncogene; 2010 Mar; 29(9):1384-93. PubMed ID: 19966869
[TBL] [Abstract][Full Text] [Related]
13. The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro.
Winston JT; Strack P; Beer-Romero P; Chu CY; Elledge SJ; Harper JW
Genes Dev; 1999 Feb; 13(3):270-83. PubMed ID: 9990852
[TBL] [Abstract][Full Text] [Related]
14. APC is essential for targeting phosphorylated beta-catenin to the SCFbeta-TrCP ubiquitin ligase.
Su Y; Fu C; Ishikawa S; Stella A; Kojima M; Shitoh K; Schreiber EM; Day BW; Liu B
Mol Cell; 2008 Dec; 32(5):652-61. PubMed ID: 19061640
[TBL] [Abstract][Full Text] [Related]
15. Modulation of SCF beta-TrCP-dependent I kappaB alpha ubiquitination by hydrogen peroxide.
Banerjee S; Zmijewski JW; Lorne E; Liu G; Sha Y; Abraham E
J Biol Chem; 2010 Jan; 285(4):2665-75. PubMed ID: 19933270
[TBL] [Abstract][Full Text] [Related]
16. Pseudosubstrate regulation of the SCF(beta-TrCP) ubiquitin ligase by hnRNP-U.
Davis M; Hatzubai A; Andersen JS; Ben-Shushan E; Fisher GZ; Yaron A; Bauskin A; Mercurio F; Mann M; Ben-Neriah Y
Genes Dev; 2002 Feb; 16(4):439-51. PubMed ID: 11850407
[TBL] [Abstract][Full Text] [Related]
17. The characteristics and roles of β-TrCP1/2 in carcinogenesis.
Bi Y; Cui D; Xiong X; Zhao Y
FEBS J; 2021 Jun; 288(11):3351-3374. PubMed ID: 33021036
[TBL] [Abstract][Full Text] [Related]
18. BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.
Coyaud E; Mis M; Laurent EM; Dunham WH; Couzens AL; Robitaille M; Gingras AC; Angers S; Raught B
Mol Cell Proteomics; 2015 Jul; 14(7):1781-95. PubMed ID: 25900982
[TBL] [Abstract][Full Text] [Related]
19. Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation.
Goupille O; Daniel N; Bignon C; Jolivet G; Djiane J
Mol Cell Endocrinol; 1997 Mar; 127(2):155-69. PubMed ID: 9099911
[TBL] [Abstract][Full Text] [Related]
20. Dual effects of IkappaB kinase beta-mediated phosphorylation on p105 Fate: SCF(beta-TrCP)-dependent degradation and SCF(beta-TrCP)-independent processing.
Cohen S; Achbert-Weiner H; Ciechanover A
Mol Cell Biol; 2004 Jan; 24(1):475-86. PubMed ID: 14673179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
